Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Eliza Slawther

Senior Writer

London, UK

Eliza began reporting on health and medical science in 2018 while completing her Master’s degree in Journalism at City, University of London. During her degree program she interned at C+D and on the London Evening Standard’s health desk. In the years since, Eliza has written about everything from mid-stage drug development to market access for medicines and devices in the EU and beyond. Her work explores the trials and tribulations of securing reimbursement for medical products in Europe, and Eliza is particularly interested in the challenges of funding innovation in health care.

Eliza has lived in London since 2017 and is originally from Cheshire, in the north west of England. She has a BA in English Literature from the University of Manchester and is in the process of completing a second undergraduate degree in Biomedicine from Birkbeck College, an evening university that is part of the University of London.

Latest From Eliza Slawther

Another Italian Notified Body Designated Under MDR

This new listing is the tenth Italian notified body under the Medical Device Regulation, bringing the total number of notified bodies to 36.

Europe EU

UK’s NICE Says ‘Light Touch’ HTA Evaluation Will Support Innovation

The UK’s health technology assessment body recognizes that its traditional product evaluation processes are too slow for innovative medtech products. Its new “conditional recommendation” pathway aims to fix this.

EU Europe

EU Data Act Must Consider ‘Sectoral Peculiarities’ Says Medtech Industry

The European Commission’s proposed Data Act is among a growing pile of horizontal regulations set to impact the medtech industry. But changes should be made to protect trade secrets and other sector-specific nuances, MedTech Europe warns.

Europe EU

Why EU Must Reform Regulation And Funding For Life-Saving Cancer Biomarker Tests

UK and EU patients have inadequate and inconsistent access to cancer biomarker tests, which experts warn is hindering the use of life-saving targeted medicines. Could parallel regulatory and reimbursement processes for drugs and diagnostics provide a solution?

Europe EU

AI Experts Tell UK MHRA How To Regulate AI Proportionately So Patients Benefit

UK policymakers will need to walk a fine line when developing regulation for AI as a medical device. An independent expert review sets out the need for carefully balanced rules that support innovation without allowing unsafe products to enter the market.

Europe EU

More Than 50% Of EU Clinicians Report Recent Medical Device Shortages

Shortages of medical devices ranging from insulin pumps to robotic surgical systems are impacting clinicians across the EU, leaving many healthcare providers without effective alternative products, a report by the Biomedical Alliance in Europe shows.

Europe EU
See All
UsernamePublicRestriction

Register